High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice

Liver

Volumn 19, Issue 3, 1999, Pages 242-252

  Snibson, Kenneth J ^a   Bhathal, Prithi S ^a   Hardy, Charles L ^a   Brandon, Malcolm R ^a   Adams, Timothy E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Apoptosis; Growth hormone; Hepatocellular carcinoma; Proliferation; Transgenic mice

Indexed keywords

BROXURIDINE; GROWTH HORMONE; METALLOTHIONEIN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL; MOUSE; NONHUMAN; PATHOLOGY; TRANSGENIC MOUSE; TUMOR GROWTH;

ADENOMA; AGE FACTORS; ANIMALS; APOPTOSIS; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; FEMALE; GROWTH HORMONE; IN SITU NICK-END LABELING; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOTIC INDEX; ORGAN SIZE;

EID: 0033045030     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00042.x     Document Type: Article

References (47)

1. ORIAN J M, LEE C S, WEISS L M, BRANDON M R. The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver. Endocrinology 1989; 124: 455-63.
2. ORIAN J M, TAMAKOSHI K, MACKAY I R, BRANDON M R. New murine model for hepatocellular carcinoma: transgenic mice expressing metallothionein-ovine growth hormone fusion gene. J Natl Cancer Inst 1990; 82: 393-8.
3. ORIAN J M, MACKAY I R, TAMAKOSHI K, LEE C S, BRANDON M R. Hepatocellular carcinoma in mice with ovine growth hormone transgene. In: HOLLINGER B, LEMON S M, AND MARGOLIS S eds. Viral hepatitis 1990. Baltimore: Williams and Wilkens, 1991: 589-92.
4. QUAIFE C J, MATHEWS L S, PINKERT C A, HAMMER R E, BRINSTER R L, PALMITER R D. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 1989; 124: 40-8.
5. WANKE R, HERMANNS W, FOLGER S, WOLF E, BREM G. Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: an overview. Pediatr Nephrol 1991; 5: 513-21.
6. HARDY C L, BHATHAL P S, SNIBSON K J, ADAMS T E. Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer. Immunology 1997; 90: 412-20.
7. CHISARI F V, KLOPCHIN K, MORIYAMA T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145-56.
8. DUNSFORD H A, SELL S, CHISARI F V. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 1990; 50: 3400-7.
9. CHISARI F V. Hepatitis B virus tansgenic mice: insights into the virus and the disease. Hepatology 1995; 22: 1316-25.
10. HUANG S N, CHISARI F V. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995; 21: 620-6.
11. VERGANI G, MAYERHOFER A, BARTKE A. Acute effects of rat growth hormone (GH), human GH and prolactin on proliferating rat liver cells in vitro: a study of mitotic behaviour and ultrastructural alterations. Tissue Cell 1994; 26: 457-65.
12. GAVRIELI Y, SHERMAN Y, BEN-SASSON S A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
13. AUFFRAY C, ROUGEON F. Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumour RNA. Eur J Biochem 1980; 107: 303-14.
14. SAMBROOK J, FRITSCH E F, MANIATIS T. (1989) Molecular cloning. A laboratory manual. 2nd. Cold Spring Harbor Press, Cold Spring Harbor, NY.
15. TAUB R. Transcriptional control of liver regeneration. FASEB J 1996; 10: 413-27.
16. WILSON J W. Diurnal rhythym of mitotic activity in the liver of the mouse. Anat Rec 1948; 101: 672-3.
17. ORIAN J M, SNIBSON K J, STEVENSON J L, BRANDON M R, HERINGTON A C. Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH. Endocrinology 1991; 128: 1238-46.
18. SNIBSON K J, WOODCOCK D, ORIAN J M, BRANDON M R, ADAMS T E. Methylation and expression of a metallothionein promoter ovine growth hormone fusion gene (MToGH1) in transgenic mice. Transgenic Res 1995; 4: 114-22.
19. SNIBSON K J, ADAMS T E. Trangene methylation in transgenic animals. In: HOUDIBINE M L, ed. Transgenic animals. Generation and use. Amsterdam: Harwood Academic Publishers, 1997: 237-43.
20. WOLF E, KAHNT E, EHRLEIN J, HERMANNS W, BREM G, WANKE R. Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models. Mech Ageing Dev 1993; 68: 71-87.
21. MESSING A, CHEN H Y, PALMITER R D, BRINSTER R L. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature 1985; 316: 461-3.
22. RICHMAN R A, CLAUS T H, PILKIS S J, FRIEDMAN D L. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci USA 1976; 73 3589-93.
23. VERGANI G, MAYERHOFER A, BARTKE A. Acute effects of human growth hormone on liver cells in vitro: a comparison with livers of mice transgenic for human growth hormone. Tissue Cell 1991; 23: 607-12.
24. UNTERMAN T G, PHILLIPS L S. Circulating somatomedin activity during hepatic regeneration. Endocrinology 1986; 119: 185-92.
25. UTHNE K; UTHNE T. Influence of liver resection and regeneration on somatomedin (sulphation factor) activity in sera from normal and hypophysectomized rats. Acta Endocrinol Copenh 1972; 71: 255-64.
26. MURPHY L J, BELL G I, FRIESEN H G. Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo. Endocrinology 1987; 120: 1806-12.
27. VERGANI G, LAHR G, WANG Z M, BARTKE A, MAYERHOFER A. Visualizing the expression of a human growth hormone (hGH) transgene in the liver: intrahepatic regional and intracellular differences of expression are associated with morphological alterations and hepatocellular proliferation. Tissue Cell 1997; 29: 611-6.
28. BARTKE A, TURYN D, AGUILAR C C, et al. Growth hormone (GH) binding and effects of gh analogs in transgenic mice. Proc Soc Exp Biol Med 1994; 206: 190-4.
29. MATHEWS L S, HAMMER R E, BRINSTER R E, PALMITER R D. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 1988; 123: 433-7.
30. GOHDA E, YAMASAKI T, TSUBOUCHI H, et al. Biological and immunological properties of hepatocyte growth factor from plasma of patients with fulminate hepatic failure. Biochim Biophys Acta 1990; 1053: 21-6.
31. BEHRINGER R R, LEWIN T M, QUAIFE C J, PALMITER R D, BRINSTER R E, D'ERCOLE A J. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 1990; 127: 1033-40.
32. EKBERG S, LUTHER M, NAKAMURA T, JANSSON J O. Growth hormone promotes early initiation of hepatocyte growth factor gene expression in the liver of hypophysectomized rats after partial hepatectomy. J Endocrinol 1992; 135: 59-67.
33. JOHANSSON S, HUSMAN B, NORSTEDT G, ANDERSSON G. Growth hormone regulates the rodent hepatic epidermal growth factor receptor at a pretranslational level. J Mol Endocrinol 1989; 3: 113-20.
34. JASSON J, EKBERG S, HOATH S B, BEAMER W G, FROHMAN L A. Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice. J Clin Invest 1988; 82: 1871-6.
35. EKBERG S, CARLSSON L, CARLSSON B, BILLIG H, JANSSON J. Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver. Endocrinology 1989; 125: 2158-66.
36. WEBBER E M, WU J C, WANG L, MERLINO G, FAUSTO N. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994; 145: 398-408.
37. MATSUI Y, HALTER S A, HOLT J T, HOGAN B L M, COFFEY R J. Development of mammary hyperplasia and neoplasia in MMTV-TGF-alpha transgenic mice. Cell 1990; 61: 1147-56.
38. SANDGREN E P, LUETTEKE N C, PALMITER R D, BRINSTER R L, LEE D C. Overexperssion of TGF-alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 61: 1121-36.
39. JHAPPAN C, STAHLE C, HARKINS R N, FAUSTO N, SMIDT G H, MERLINO G T. TGF-alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the Mammary gland and pancreas. Cell 1990; 61: 1137-46.
40. YAMAUCHI T, UEKI K, TOBE K, et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 1997; 390: 91-6.
41. TRUMP B F, BEREZESKY I K, CHANG S H, PHELPS P C. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol 1997; 25: 82-8.
42. COLUMBAO A. Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 1995; 58: 181-90.
43. HAGEN T M, HUANG S, CURNUTTE J, et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994; 91: 12808-12.
44. GRASLKRAUPP B, RUTTKAYNEDECKY B, MULLAUER L, et al. Inherent increase of apoptosis in liver tumors - Implications for carcinogenesis and tumor regression. Hepatology 1997; 25: 906-12.
45. HINO N, HIGASHI T, NOUSO K, NAKATSUKASA H, TSUJI T. Apoptosis and proliferation of human hepatocellular carcinoma. Liver 1996; 16: 123-9.
46. ISACSON C, KESSIS T D, HEDRICK L, CHO K R. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 1996; 56: 669-74.
47. TSUJI H, HARADA A, MUKAIDA N, et al. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apcptosis in a murine model of bacterium-induced fulminate hepatitis. Infect Immun 1997; 65: 1892-8.